METABOLOMIC AND LIPIDOMIC ANALYSIS OF PATIENTS WITH PRESUMED METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) TREATED WITH THE SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR MIRICORILANT

被引：0
|
作者：
Kowdley, Kris [1 ]
Noureddin, Mazen [2 ]
Parks, Elizabeth [3 ]
Botbyl, Jeffrey [4 ]
Monibas, Rafael Mayoral [4 ]
Wadekar, Subhagya [4 ]
Espinueva, Aprille [4 ]
Juneja, Kavita [4 ]
Schwab, Andrew [5 ]
Alkhouri, Naim [6 ]
机构：
[1] Liver Inst Northwest, Seattle, WA USA
[2] Houston Methodist Hosp, Houston, TX USA
[3] Univ Missouri, Columbia, MO USA
[4] Corcept Therapeut Inc, Menlo Pk, CO USA
[5] Metabolon, Durham, NC USA
[6] Arizona Liver Hlth, Phoenix, AZ USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1637
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes
    Wada, Tsutomu
    Takeda, Yuki
    Okekawa, Akira
    Komatsu, Go
    Iwasa, Yuichi
    Onogi, Yasuhiro
    Takasaki, Ichiro
    Hamashima, Takeru
    Sasahara, Masakiyo
    Tsuneki, Hiroshi
    Sasaoka, Toshiyasu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [32] 15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)
    Aminian, Ali
    ALJabri, Abdullah
    Wang, Sarah
    Bena, James
    Allende, Daniela
    Rosen, Hana
    Wilson, Rickesha
    Milinovich, Alex
    Loomba, Rohit
    Sanyal, Arun J.
    Alkhouri, Naim
    Wakim-Fleming, Jamile
    Dasarathy, Srinivasan
    McCullough, Arthur
    Nissen, Steven
    JOURNAL OF HEPATOLOGY, 2024, 80 : S76 - S77
  • [33] Circulating Neutrophil Profiles Undergo a Dynamic Shift during Metabolic Dysfunction-Associated Steatohepatitis (MASH) Progression
    Maretti-Mira, Ana C.
    Salomon, Matthew P.
    Chopra, Shefali
    Yuan, Liyun
    Golden-Mason, Lucy
    BIOMEDICINES, 2024, 12 (05)
  • [34] Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
    Lam, Brian P.
    Bartholomew, Jessica
    Bau, Sherona
    Gilles, Hochong
    Keller, Andrea
    Moore, Ann
    Nader, Khalil
    Richards, Lisa
    Henry, Linda
    Younossi, Zobair M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2025, 59 (04) : 298 - 309
  • [35] ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
    Kim, Do Han
    Ko, Donghyun
    Corral, Juan E.
    Kroner, Paul T.
    Lukens, Frank
    Argueta, Pedro Palacios
    GASTROENTEROLOGY, 2024, 166 (05) : S1663 - S1664
  • [36] MACHINE LEARNING MODELS FOR PREDICTING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE GENERAL UNITED STATES POPULATION
    Khalid, J.
    Aparasu, R. R.
    VALUE IN HEALTH, 2024, 27 (06) : S268 - S268
  • [37] Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria
    Pennisi, Grazia
    Enea, Marco
    Romero-Gomez, Manuel
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Fracanzani, Anna Ludovica
    de Ledinghen, Victor
    George, Jacob
    Berzigotti, Annalisa
    Vigano, Mauro
    Sebastiani, Giada
    Cannella, Roberto
    Delamarre, Adele
    Di Maria, Gabriele
    Lange, Naomi F.
    Tulone, Adele
    Di Marco, Vito
    Camma, Calogero
    Petta, Salvatore
    HEPATOLOGY, 2024, 79 (04) : 912 - 925
  • [38] REAL-WORLD OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) COMPENSATED CIRRHOSIS AT A LARGE ACADEMIC REFERRAL CENTER
    Slatter, Shadera
    Guillot, Jordan
    Williams, Christopher
    Watanabe, Alexandre
    Chaudhri, Eirum
    Zhang, Xiao
    Fernandes, Gail
    Ge, Jin
    Rudrapatna, Vivek
    HEPATOLOGY, 2024, 80 : S860 - S861
  • [39] THERAPEUTIC HORIZONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE( MASLD) & METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS( MASH): A SYSTEMATIC REVIEW OF CURRENT TREATMENT OPTION
    Moliya, Pratiksha
    Al-Obaidi, Hasan
    Patel, Pranav
    Patel, Raj
    Parikh, Charmy
    Joy, Melvin
    HEPATOLOGY, 2024, 80
  • [40] Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective
    Younossi, Zobair M.
    Razavi, Homie
    Sherman, Michael
    Allen, Alina M.
    Anstee, Quentin M.
    Cusi, Kenneth
    Friedman, Scott L.
    Lawitz, Eric
    Lazarus, Jeffrey V.
    Schuppan, Detlef
    Romero-Gomez, Manuel
    Schattenberg, Joern M.
    Vos, Miriam B.
    Wong, Vincent Wai-Sun
    Ratziu, Vlad
    Hompesch, Marcus
    Sanyal, Arun J.
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
12345